# A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)

> **NCT06455098** · NA · RECRUITING · sponsor: **Biosense Webster, Inc.** · enrollment: 440 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** OMNYPULSE™ Catheter with the TRUPULSE Generator

## Key facts

- **NCT ID:** NCT06455098
- **Lead sponsor:** Biosense Webster, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-28
- **Primary completion:** 2026-05-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 440 (ESTIMATED)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06455098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06455098, "A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06455098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*